2023
“I’d like more options!”: Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis
Toupin-April K, Gaboury I, Proulx L, Huber A, Duffy C, Morgan E, Li L, Stringer E, Connelly M, Weiss J, Gibbon M, Sachs H, Sivakumar A, Sirois A, Sirotich E, Trehan N, Abrahams N, Cohen J, Cavallo S, Hindi T, Ragusa M, Légaré F, Brinkman W, Fortin P, Décary S, Lee R, Gmuca S, Paterson G, Tugwell P, Stinson J. “I’d like more options!”: Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis. Pediatric Rheumatology 2023, 21: 74. PMID: 37491246, PMCID: PMC10369758, DOI: 10.1186/s12969-023-00849-0.Peer-Reviewed Original ResearchConceptsPain management optionsHealth care providersParents/caregiversPain managementIdiopathic arthritisPediatric health care providersBackgroundJuvenile idiopathic arthritisPain management discussionsPediatric rheumatic conditionsOttawa Decision Support FrameworkHealth-related qualityJuvenile idiopathic arthritisQualitative descriptive study designYears of ageDecision support interventionsBetter health outcomesDescriptive study designEvidence-based informationManagement optionsQuality improvement networkRheumatology nursesRheumatology consultationJoint painHCP trainingNonpharmacological approaches
2021
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, Conway R, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard RA, Hoyer BF, Hsieh E, Kibbi L, Kilian A, Kim AH, Liew DFL, Lo C, Miller B, Mingolla S, Nudel M, Palmerlee CA, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché M, Levine M, Foster G, Thabane L, Rider LG, Hausmann JS, Simard JF, Sparks JA. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open 2021, 7: e001814. PMID: 34493645, PMCID: PMC8424419, DOI: 10.1136/rmdopen-2021-001814.Peer-Reviewed Original ResearchConceptsDisease-modifying antirheumatic drugsPatient-reported adverse eventsSystemic rheumatic diseasesCOVID-19 vaccinationRheumatic disease flareRheumatic diseasesDisease flareCOVID-19 vaccineAdverse eventsVaccine efficacyMuscle/joint painJanssen/JohnsonTime of vaccinationFever/chillsCommon rheumatic diseasePatient-reported dataOxford/AstraZenecaEarly experienceVaccines surveyAntirheumatic drugsMedication changesJoint painMost patientsPfizer-BioNTechRheumatoid arthritis